Diosmin and hesperidin for H. pylori infection
Part of Digestive system, Infections clinical trials.
This trial tests whether a combination of two natural plant compounds, diosmin and hesperidin, can safely and effectively treat Helicobacter pylori (H. pylori) infection in people who have not been treated for it before. The goal is to see if this therapy offers a new option for clearing the bacteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed H. pylori infection from a stool test.
- You have never received treatment for H. pylori before.
- You are between 18 and 75 years old.
- You are able to understand and follow the study procedures.
- You are not pregnant or breastfeeding, and are not taking certain medications like blood thinners, anti-seizure drugs, muscle relaxants, NSAIDs, or anti-inflammatory drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called Pylori Duo for people newly diagnosed with H. pylori infection. It aims to both treat the infection and prevent it from coming back.
This trial tests a new two-step antibiotic treatment for adults with chronic gastritis caused by H. pylori bacteria. If you have not been treated for H. pylori before and are between 18 and 70, you may be able to join.
This trial compares two treatments for H. pylori infection: a high-dose two-drug regimen and a four-drug regimen containing minocycline. It aims to find which is more effective and better tolerated.
This study tests a combination of a probiotic (Saccharomyces boulardii) plus a standard bismuth-based four-drug treatment for people whose H. pylori infection has not been cured by previous treatments. It aims to see if adding the probiotic helps the treatment work better and cause fewer side effects.
This study compares two different antibiotic treatment plans for H. pylori, a common stomach bacteria that causes ulcers and digestive problems. The trial tests whether a higher dose of one medication (vonoprazan) works better than a different antibiotic combination.
This trial is for adults aged 18 to 80 who have a Helicobacter pylori (H. pylori) infection in their stomach and have never been treated for it. The study will look at how treating the infection affects symptoms like indigestion or stomach pain.
Hear when a new Helicobacter Pylori Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.